Pernod Ricard (ENXTPA:RI) is in focus after first quarter organic sales declined 0.9%, a smaller drop than expected, and management began preparing a potential IPO of its Indian unit.
The sales update highlighted softer trends in the US and China, while India and higher overall volumes provided a partial offset and kept organic net sales expectations for the year broadly stable.
The first quarter update and potential India IPO have arrived after a mixed run for Pernod Ricard, with the 7 day share price return of 9% and 30 day gain of 9.61% contrasting with a year to date share price decline of 8.74% and a 1 year total shareholder return that is down 18.06%. This indicates that momentum has strengthened recently even as longer term returns remain weak.
Scan beyond Pernod Ricard and find other consumer stocks where recent share price swings and fresh catalysts could matter most using our hand-picked 195 high quality undervalued stocks.
Pernod Ricard still owns a powerful portfolio and a long operating history, yet the share price has only just bounced off a weak year. Is the recent rerating already generous or still cautious?
The most followed narrative on Pernod Ricard pegs fair value at €81.76, above the recent €66.60 close. This frames the current debate around whether investors are being too cautious on this spirits group.
The company is poised to benefit from rising spirits consumption across emerging markets, particularly India, Southeast Asia, and Africa, driven by demographic and income growth; this is expected to accelerate long-term top-line revenue as these regions continue to urbanize and expand their middle class.
See why 44 investors see Pernod Ricard as 19% undervalued.
Result: Fair Value of €81.76 (UNDERVALUED)
Still, the narrative can unravel if weakness in the US and China lingers, or if tighter alcohol regulation and taxes further pressure Pernod Ricard’s margins.
Find out about the key risks to this Pernod Ricard narrative.
If the mixed sentiment on Pernod Ricard leaves you undecided, move quickly to check the full picture and weigh both sides for yourself. To see how investors are balancing caution and optimism, review the 3 key rewards and 2 important warning signs
If Pernod Ricard has sharpened your thinking, do not stop there. Broaden your watchlist with other focused ideas that match different goals and risk levels.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com